TipRanks
Pharma Foods International Co., Ltd. (JP:2929)
:2929
Japanese Market
Want to see JP:2929 full AI Analyst Report?

Pharma Foods International Co., Ltd. (2929) Ratios

1 Followers

Pharma Foods International Co., Ltd. Ratios

JP:2929's free cash flow for Q4 2026 was ¥0.78. For the 2026 fiscal year, JP:2929's free cash flow was decreased by ¥ and operating cash flow was ¥0.28. See a summary of the company’s cash flow.
Ratios
TTM
Jul 26Jul 25Jul 24Jul 23
Liquidity Ratios
Current Ratio
1.26 1.26 1.19 1.18 1.13
Quick Ratio
0.76 0.76 0.80 0.89 0.88
Cash Ratio
0.43 0.43 0.45 0.68 0.67
Solvency Ratio
0.12 0.12 0.05 0.16 0.14
Operating Cash Flow Ratio
-0.06 -0.06 -0.05 0.24 0.25
Short-Term Operating Cash Flow Coverage
-0.08 -0.08 -0.09 0.35 0.33
Net Current Asset Value
¥ 1.08B¥ 1.08B¥ 2.64B¥ 2.29B¥ 928.00M
Leverage Ratios
Debt-to-Assets Ratio
0.49 0.49 0.39 0.46 0.55
Debt-to-Equity Ratio
1.30 1.30 1.10 1.46 2.09
Debt-to-Capital Ratio
0.57 0.57 0.52 0.59 0.68
Long-Term Debt-to-Capital Ratio
0.20 0.20 0.05 0.10 0.15
Financial Leverage Ratio
2.67 2.67 2.84 3.16 3.76
Debt Service Coverage Ratio
0.21 0.21 0.09 0.27 0.20
Interest Coverage Ratio
16.35 16.35 26.03 82.47 75.21
Debt to Market Cap
0.81 1.06 0.50 0.54 0.42
Interest Debt Per Share
598.25 598.10 443.59 596.08 697.59
Net Debt to EBITDA
2.78 2.78 1.14 0.20 0.91
Profitability Margins
Gross Profit Margin
80.13%80.13%80.49%78.45%80.61%
EBIT Margin
4.16%4.16%3.63%8.20%5.26%
EBITDA Margin
5.33%5.33%4.83%9.66%6.06%
Operating Profit Margin
4.16%4.16%3.63%8.23%5.26%
Pretax Profit Margin
3.68%3.68%3.73%8.10%5.17%
Net Profit Margin
3.14%3.14%0.56%5.16%4.49%
Continuous Operations Profit Margin
3.15%3.15%0.56%5.16%4.49%
Net Income Per EBT
85.43%85.43%15.12%63.67%86.98%
EBT Per EBIT
88.38%88.38%102.74%98.45%98.12%
Return on Assets (ROA)
5.66%5.66%1.12%8.76%8.50%
Return on Equity (ROE)
18.75%15.10%3.19%27.67%31.99%
Return on Capital Employed (ROCE)
15.63%15.63%18.54%38.13%30.44%
Return on Invested Capital (ROIC)
7.30%7.30%1.45%11.20%10.39%
Return on Tangible Assets
5.68%5.68%1.13%8.81%8.56%
Earnings Yield
9.40%12.29%1.44%10.24%6.37%
Efficiency Ratios
Receivables Turnover
15.85 15.85 12.35 14.47 14.97
Payables Turnover
8.89 8.89 6.62 10.72 14.19
Inventory Turnover
1.37 1.37 1.62 1.99 2.20
Fixed Asset Turnover
7.89 7.89 13.90 13.48 15.57
Asset Turnover
1.80 1.80 1.99 1.70 1.89
Working Capital Turnover Ratio
22.30 14.65 16.36 17.10 35.40
Cash Conversion Cycle
247.60 247.60 199.51 174.19 164.86
Days of Sales Outstanding
23.04 23.04 29.56 25.22 24.39
Days of Inventory Outstanding
265.62 265.62 225.10 183.03 166.20
Days of Payables Outstanding
41.05 41.05 55.14 34.06 25.73
Operating Cycle
288.65 288.65 254.66 208.25 190.59
Cash Flow Ratios
Operating Cash Flow Per Share
-40.56 -40.55 -37.99 192.89 212.11
Free Cash Flow Per Share
-179.11 -179.06 -68.99 158.68 198.08
CapEx Per Share
138.55 138.52 31.00 34.21 14.03
Free Cash Flow to Operating Cash Flow
4.42 4.42 1.82 0.82 0.93
Dividend Paid and CapEx Coverage Ratio
-0.25 -0.25 -0.65 3.43 6.23
Capital Expenditure Coverage Ratio
-0.29 -0.29 -1.23 5.64 15.12
Operating Cash Flow Coverage Ratio
-0.07 -0.07 -0.09 0.32 0.30
Operating Cash Flow to Sales Ratio
-0.02 -0.02 -0.02 0.09 0.09
Free Cash Flow Yield
-24.47%-32.09%-7.78%14.41%11.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.69 8.13 69.30 9.77 15.71
Price-to-Sales (P/S) Ratio
0.34 0.26 0.39 0.50 0.71
Price-to-Book (P/B) Ratio
1.61 1.23 2.21 2.70 5.03
Price-to-Free Cash Flow (P/FCF) Ratio
-4.09 -3.12 -12.86 6.94 8.46
Price-to-Operating Cash Flow Ratio
-18.00 -13.76 -23.35 5.71 7.90
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.02 -0.78 1.74 -0.02
Price-to-Fair Value
1.61 1.23 2.21 2.70 5.03
Enterprise Value Multiple
9.08 7.58 9.23 5.42 12.56
Enterprise Value
30.58B 25.55B 29.10B 32.54B 52.19B
EV to EBITDA
9.08 7.58 9.23 5.42 12.56
EV to Sales
0.48 0.40 0.45 0.52 0.76
EV to Free Cash Flow
-5.89 -4.92 -14.67 7.21 9.12
EV to Operating Cash Flow
-26.03 -21.74 -26.65 5.93 8.52
Tangible Book Value Per Share
451.62 451.51 397.67 401.11 325.25
Shareholders’ Equity Per Share
454.45 454.34 401.74 407.33 333.49
Tax and Other Ratios
Effective Tax Rate
0.15 0.15 0.85 0.36 0.13
Revenue Per Share
2.18K 2.18K 2.27K 2.19K 2.37K
Net Income Per Share
68.62 68.60 12.80 112.69 106.70
Tax Burden
0.85 0.85 0.15 0.64 0.87
Interest Burden
0.88 0.88 1.03 0.99 0.98
Research & Development to Revenue
0.03 0.03 0.02 0.02 0.01
SG&A to Revenue
0.73 0.73 0.75 0.19 0.06
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-0.59 -0.59 -2.97 1.09 1.73
Currency in JPY